In a research report released Friday, Chardan analyst Gbola Amusa initiated coverage on shares of Uniqure NV (NASDAQ:QURE) with a Buy rating and a $40 …
H.C.
On Monday, Uniqure NV (NASDAQ:QURE) and Bristol-Myers Squibb Co (NYSE:BMY) announced an exclusive strategic collaboration in which the agreement gives Bristol-Myers “exclusive …
Uniqure NV (NASDAQ:QURE) shares were on the rise Monday after the company announced a landmark platform deal with Bristol-Myers Squibb Co (NYSE:BMY) which will include the company's proprietary …
